Wordt geladen...
Nebulized dexmedetomidine improves pulmonary shunt and lung mechanics during one-lung ventilation: a randomized clinical controlled trial
BACKGROUND: Dexmedetomidine (Dex), a selective a(2)-adrenergic receptor agonist, has been previously reported to attenuate intrapulmonary shunt during one-lung ventilation (OLV) and to alleviate bronchoconstriction. However, the therapeutic effects of nebulized Dex on pulmonary shunt and lung mechan...
Bewaard in:
| Gepubliceerd in: | PeerJ |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
PeerJ Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7278887/ https://ncbi.nlm.nih.gov/pubmed/32547872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.9247 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|